Pioneering the Next Frontier: ArisGlobal Unveils Cutting-Edge Safety & Regulatory Product Offerings Powered by Generative AI

in 2023.

Commenting on the announcements, Aman Wasan, CEO of ArisGlobal, said: "Bringing cutting-edge technologies like Generative AI to life as part of the LifeSphere R&D ecosystem is a strategic objective for ArisGlobal. Digital process transformation is vital for companies bringing ambitious, novel treatments and therapies to market efficiently. We're harnessing advanced technology, hand in hand with insights from comprehensive Real-World Data, to transform drug discovery and development. Today's announcements mark the latest moves toward this goal, and we are just getting started."

Breakthrough2024 is taking place March 19-20 at the Leonardo Royal Hotel St Paul's in London, UK.

For more information visit https://www.arisglobal.com/breakthrough or follow ArisGlobal on LinkedIn.  

About ArisGlobal
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com.

Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/pioneering-the-next-frontier-arisglobal-unveils-cutting-edge-safety--regulatory-product-offerings-powered-by-generative-ai-302092462.html

en | boerse | 67969704 |